Systemic Lupus Erythematosus Clinical Trials

899 clinical trials for Systemic Lupus Erythematosus across international registries, including 202 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants — RECRUITING · PHASE3
• A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease — RECRUITING · PHASE3
• Anifrolumab Malignancy and Serious Infections Study — RECRUITING
• An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — RECRUITING · PHASE3
• Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone — RECRUITING · PHASE4
• Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs） — RECRUITING · PHASE1
• Multinational, Interventional, 52-week, Open-label, Single-arm Study to Evaluate the Treatment Outcomes of Anifrolumab 120 mg Subcutaneous Once Weekly in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus (SUNFLOWER) — RECRUITING · PHASE3
• The Anifrolumab PRIM Program — RECRUITING
• A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA) — RECRUITING · PHASE1
• Randomised, placebo-controlled, double-blind, parallel-group Phase II study to evaluate the efficacy and safety of oral BI 3000202 in patients with moderate to severe systemic lupus erythematosus (SLE) — RECRUITING · PHASE2
• Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders — RECRUITING · NA
• A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus — RECRUITING · PHASE3
• A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus — RECRUITING · PHASE3
• A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases — RECRUITING · PHASE2
• A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) — RECRUITING · PHASE2
• Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease — RECRUITING · PHASE3
• Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires — RECRUITING
• Study of Systemic Lupus Erythematosus — RECRUITING
• A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) — RECRUITING · PHASE1
• A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease — RECRUITING · PHASE1
• Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus — RECRUITING · PHASE1
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO — RECRUITING · PHASE1
• Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants — RECRUITING · PHASE1
• Systemic Lupus Erythematosus in Gullah Health — RECRUITING
• A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis — RECRUITING · PHASE2
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus — RECRUITING · PHASE2
• Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions — RECRUITING
• A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus — RECRUITING · PHASE3
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis. — RECRUITING · PHASE1
• Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users — RECRUITING · PHASE4
• A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants — RECRUITING
• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases — RECRUITING · PHASE4
• The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD — RECRUITING · PHASE2
• A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA) — RECRUITING · PHASE1
• INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use — RECRUITING
• A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE) — RECRUITING · PHASE1
• A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus — RECRUITING · PHASE1
• Anifrolumab Pregnancy Study — RECRUITING
• A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus — RECRUITING · PHASE2
• Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). — RECRUITING · PHASE3
• A Study of E6742 in Participants With Systemic Lupus Erythematosus — RECRUITING · PHASE2
• A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA) — RECRUITING · PHASE1
• Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus — RECRUITING
• MTS109 in Patients With Refractory Autoimmune Diseases — RECRUITING · PHASE1
• Immun4Cure Cohort of Autoimmune Diseases — RECRUITING
• Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus — RECRUITING · PHASE1
• Biomarker Development for Autoimmune Disorders Involving the Kidneys — RECRUITING
• A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus — RECRUITING · PHASE1
• Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE) — RECRUITING
• Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU — RECRUITING

Refine this search